Please use this identifier to cite or link to this item: http://archive.cmb.ac.lk:8080/xmlui/handle/70130/5126
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLokuhetty, M D S-
dc.contributor.authorWijesinghe, Harshima D-
dc.contributor.authorDamen, Johanna AAG-
dc.contributor.authorLee T, Teresa-
dc.contributor.authorWhite, Valerie A-
dc.contributor.authorCree, Ian A-
dc.date.accessioned2021-03-11T12:16:55Z-
dc.date.available2021-03-11T12:16:55Z-
dc.date.issued2020-
dc.identifier.citationLokuhetty MDS, Wijesinghe HD, Damen JAAG, Lee T, White VA, Cree IA, Indave BIciar. Prognostic value of the androgen receptor in addition to the established hormone receptors and HER2 status for predicting survival in women with early breast cancer. Cochrane Database of Systematic Reviews 2020, Issue 11. Art. No.: CD013784. DOI: 10.1002/14651858.CD013784.en_US
dc.identifier.urihttp://archive.cmb.ac.lk:8080/xmlui/handle/70130/5126-
dc.language.isoenen_US
dc.publisherWiley & Sons Ltden_US
dc.subjectBreast Canceren_US
dc.titlePrognostic value of the androgen receptor in addition to the established hormone receptors and HER2 status for predicting survival in women with early breast canceren_US
dc.typeArticleen_US
Appears in Collections:Journal Articles



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.